These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2963586)

  • 81. Influence of arterio-venous haemofiltration on teicoplanin elimination.
    Hillaire-Buys D; Peyriere H; Lobjoie E; Bres J; Ossart M; Despaux E
    Br J Clin Pharmacol; 1995 Jul; 40(1):95-7. PubMed ID: 8527277
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comparison of predictive accuracy of teicoplanin concentration using creatinine clearance and glomerular filtration rate estimated by serum creatinine or cystatin C.
    Kozono A; Hiraki Y; Adachi R; Nagano M; Inoue D; Tsuji Y; Kamimura H; Karube Y
    J Infect Chemother; 2016 May; 22(5):314-8. PubMed ID: 26923258
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pharmacokinetics of a single dose of teicoplanin in burn patients.
    Steer JA; Papini RP; Wilson AP; Dhillon S; Hichens MF; McGrouther DA; Frame JD; Parkhouse N
    J Antimicrob Chemother; 1996 Mar; 37(3):545-53. PubMed ID: 9182111
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Teicoplanin: Part 1. An evaluation of the concentrations seen in serum and the subcutaneous fat of the relatively ischaemic lower limb following a single intravenous bolus.
    Antrum RM; Bibby SR; Ramsden CH; Kester RC
    Drugs Exp Clin Res; 1989; 15(1):21-3. PubMed ID: 2526008
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pharmacokinetics of teicoplanin in critically ill patients undergoing continuous hemodiafiltration.
    Yagasaki K; Gando S; Matsuda N; Kameue T; Ishitani T; Hirano T; Iseki K
    Intensive Care Med; 2003 Nov; 29(11):2094-5. PubMed ID: 14504724
    [No Abstract]   [Full Text] [Related]  

  • 86. Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K; Suzuki H; Saruta T; Deguchi N; Fugono T
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1048-52. PubMed ID: 1929242
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pharmacokinetics of lomefloxacin in renally compromised patients.
    Blum RA; Schultz RW; Schentag JJ
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2364-8. PubMed ID: 2088191
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Reassessment of the single intravenous injection method with inulin for measurement of the glomerular filtration rate in man.
    Prescott LF; Freestone S; McAuslane JA
    Clin Sci (Lond); 1991 Feb; 80(2):167-76. PubMed ID: 1848170
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Glycopeptide antibiotics: eremomycin, vancomycin, and teicoplanin. Comparison of several parameters of pharmacokinetics and antimicrobial activity].
    Filippos'iants ST; Malkova IV; Gol'dberg LE
    Antibiot Khimioter; 1989 Jul; 34(7):523-6. PubMed ID: 2530944
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency.
    Kneer J; Tam YK; Blouin RA; Frey FJ; Keller E; Stathakis C; Luginbuehl B; Stoeckel K
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1952-7. PubMed ID: 2610506
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Fever and associated changes in glomerular filtration rate erase anticipated diurnal variations in aminoglycoside pharmacokinetics.
    Fauvelle F; Perrin P; Belfayol L; Boukari M; Cherrier P; Bosio AM; Tod M; Coulaud JM; Petitjean O
    Antimicrob Agents Chemother; 1994 Mar; 38(3):620-3. PubMed ID: 8203864
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacokinetics of cefpiramide in volunteers with normal or impaired renal function.
    Conte JE
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1585-8. PubMed ID: 3435107
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pharmacokinetics of multiple doses of teicoplanin in Chinese elderly critical patients.
    Wang S; Lin F; Ruan J; Ye H; Wang L
    Expert Rev Clin Pharmacol; 2018 May; 11(5):537-541. PubMed ID: 29506414
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effect of age and renal function on cefonicid pharmacokinetics.
    Trang JM; Monson TP; Ackerman BH; Underwood FL; Manning JT; Kearns GL
    Antimicrob Agents Chemother; 1989 Feb; 33(2):142-6. PubMed ID: 2719458
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis.
    Nakano T; Nakamura Y; Takata T; Irie K; Sano K; Imakyure O; Mishima K; Futagami K
    Int J Clin Pharm; 2016 Aug; 38(4):908-14. PubMed ID: 27125378
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Efficacy and pharmacokinetics of teicoplanin in hemodialysis patients.
    Beckers B; Brodersen HP; Stolpmann RM; Jansen G; Larbig D
    Infection; 1993; 21(1):71-4. PubMed ID: 8449588
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Glycopeptides and nephrotoxicity.
    Chow AW; Azar RM
    Intensive Care Med; 1994 Nov; 20 Suppl 4():S23-9. PubMed ID: 7699153
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing.
    Guay DR; Awni WM; Halstenson CE; Kenny MT; Keane WF; Matzke GR
    Antimicrob Agents Chemother; 1989 Nov; 33(11):2012-5. PubMed ID: 2532874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.